Weight Change Among Users of Three Progestin-Only Methods of Contraception Over a 12-Month Time Period
Completed
- Conditions
- Weight Change
- Registration Number
- NCT01592058
- Lead Sponsor
- Washington University School of Medicine
- Brief Summary
The purpose of this study is to learn whether women who use progestin-only methods of birth control such as the contraceptive implant (Implanon), the levonorgestral-releasing IUS (Mirena), or depot medroxyprogesterone acetate(DMPA) will experience weight change compared to women using the non-hormonal copper IUC (ParaGard).
The investigators primary hypothesis is that users of DMPA will gain excess weight and increase their BMI above the copper-IUC users; secondarily, the investigators will compare users' data in the LNG-IUC and ENG implant groups to the copper-IUC group.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 427
Inclusion Criteria
- Patients enrolled in CHOICE between the ages of 18 and 45 who consented to future studies
- Chose levonorgestrel-releasing IUD, copper IUD, the implant, or DMPA as their CHOICE baseline method
- Has baseline height and weight data collected from the on-campus enrollment site
- Able to come back to the on-campus enrollment site for consent process and enrollment activities
Read More
Exclusion Criteria
- Recent history of DMPA use before starting their baseline CHOICE method
- Used current method for less than 11 months or more than 12 months and three weeks
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Weight Baseline and 12 months Change in weight from baseline at 12 months.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Washington University School of Medicine
🇺🇸Saint Louis, Missouri, United States